%0 Journal Article %J J Cell Physiol %D 2019 %T Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. %A Mazzoni, Elisa %A Frontini, Francesca %A Rotondo, John Charles %A Zanotta, Nunzia %A Fioravanti, Arianna %A Minelli, Francesca %A Torreggiani, Elena %A Campisciano, Giuseppina %A Marcuzzi, Annalisa %A Guerra, Giovanni %A Tommasini, Alberto %A Touzé, Antoine %A Martini, Fernanda %A Tognon, Mauro %A Comar, Manola %X

Recent data indicate that the Simian virus 40 (SV40) infection appears to be transmitted in humans independently from early SV40-contaminated antipolio vaccines. Serum antibodies against SV40 large T antigen (Tag) were analyzed in children/adolescents and young adults. To investigate antibodies reacting to SV40 Tag antigens, serum samples ( n = 812) from children and young adults were analyzed by indirect ELISAs using specific SV40 Tag mimotopes. Mimotopes were synthetic peptides corresponding to SV40 Tag epitopes. In sera ( n = 412) from healthy children up to 17 years old, IgG antibodies against SV40 Tag mimotopes reached an overall prevalence of 15%. IgM antibodies against SV40 Tag were detected in sera of children 6-8 months old confirming and extending the knowledge that SV40 seroconversion occurs early in life. In children/adolescents affected by different diseases ( n = 180) SV40 Tag had a prevalence of 18%, being the difference no significant compared to healthy subjects ( n = 220; 16%) of the same age. Our immunological data indicate that SV40 circulates in children and young adults, both in healthy conditions and affected by distinct diseases. The IgM detection in sera from healthy children suggests that the SV40 infection/seroconversion occurs early in life (>6 months). Our immunological data support the hypothesis that SV40, or a closely related still unknown polyomavirus, infects humans. The SV40 seroprevalence is lower than common polyomaviruses, such as BKPyV and JCPyV, and other new human polyomaviruses. In addition, our immunological surveillance indicates a lack of association between different diseases, considered herein, and SV40.

%B J Cell Physiol %V 234 %P 3170-3179 %8 2019 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/30362540?dopt=Abstract %R 10.1002/jcp.27490 %0 Journal Article %J Int J Mol Sci %D 2018 %T The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases. %A Bernardi, Stella %A Marcuzzi, Annalisa %A Piscianz, Elisa %A Tommasini, Alberto %A Fabris, Bruno %K Anti-Inflammatory Agents %K Cardiovascular Diseases %K Humans %K Hypolipidemic Agents %K Immune System %K Inflammation %K Interleukins %K Lipid Metabolism %K Lipids %K Metabolic Diseases %X

Lipids and inflammation regulate each other. Early studies on this topic focused on the systemic effects that the acute inflammatory response-and interleukins-had on lipid metabolism. Today, in the era of the obesity epidemic, whose primary complications are cardio-metabolic diseases, attention has moved to the effects that the nutritional environment and lipid derangements have on peripheral tissues, where lipotoxicity leads to organ damage through an imbalance of chronic inflammatory responses. After an overview of the effects that acute inflammation has on the systemic lipid metabolism, this review will describe the lipid-induced immune responses that take place in peripheral tissues and lead to chronic cardio-metabolic diseases. Moreover, the anti-inflammatory effects of lipid lowering drugs, as well as the possibility of using anti-inflammatory agents against cardio-metabolic diseases, will be discussed.

%B Int J Mol Sci %V 19 %8 2018 Dec 14 %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/30558209?dopt=Abstract %R 10.3390/ijms19124058 %0 Journal Article %J J Rheumatol %D 2018 %T Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis. %A Ferrara, Giovanna %A Pastore, Serena %A Sancin, Lara %A Torelli, Lucio %A Radillo, Oriano %A Bramuzzo, Matteo %A Bibalo, Chiara %A Tommasini, Alberto %A Ventura, Alessandro %A Taddio, Andrea %X

OBJECTIVE: This study aimed to test fecal calprotectin (FC) as a screening tool to identify inflammatory bowel disease (IBD) among patients with juvenile idiopathic arthritis (JIA).

METHODS: FC level < 100 g/kg was considered normal. Patients with 2 consecutive FC dosage ≥ 100 g/kg underwent endoscopic evaluation.

RESULTS: There were 113 patients with JIA enrolled. FC was raised in 7 patients out of 113. All patients had IBD. In 3/7 patients, high FC levels were the only sign consistent with IBD.

CONCLUSION: FC is a useful, economical, and noninvasive diagnostic tool to identify JIA patients with underlying IBD.

%B J Rheumatol %V 45 %P 1418-1421 %8 2018 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/29907671?dopt=Abstract %R 10.3899/jrheum.171200 %0 Journal Article %J Gene %D 2018 %T Genetic profile of patients with early onset inflammatory bowel disease. %A Girardelli, Martina %A Basaldella, Federica %A Paolera, Sara Della %A Vuch, Josef %A Tommasini, Alberto %A Martelossi, Stefano %A Crovella, Sergio %A Bianco, Anna Monica %K Age of Onset %K Autophagy-Related Proteins %K Child %K Child, Preschool %K Computer Simulation %K Female %K Genetic Predisposition to Disease %K Genome-Wide Association Study %K Humans %K Infant %K Inflammatory Bowel Diseases %K Interleukin-10 %K Male %K Nod2 Signaling Adaptor Protein %K Polymorphism, Single Nucleotide %K Receptors, Interleukin %K Receptors, Interleukin-10 %K Sequence Analysis, DNA %K X-Linked Inhibitor of Apoptosis Protein %X

Inflammatory Bowel disease (IBD) is a widespread pathological condition with clinical heterogeneity and with different levels of severity. Although IBD usually occurs in young adults, onset in childhood and infancy are described in patients within the 10th and second year of age. By genome-wide association studies and meta-analysis, several genetic loci have been identified associated with an increased risk of developing IBD in Western populations with variants that may alter the normal mucosal immunity in the gastrointestinal tract. The clinical complexity and the heterogeneity of the IBD phenotype probably reflect the presence of genetic heterogeneity where different genes or combinations of them may be involved, together with environmental factors. We hypothesized that patients with early onset IBD could have either more severe genetic variants in genes associated with IBD or multiple variants in different genes. Under the multifactorial diseases is crucial to consider the small contribution of a single variant in all not only to other small variations in the same gene but also in different genes belonging to the same pathway. We performed direct gene sequencing looking for 94 variations in NOD2, ATG16L1, IL23R, IL10R, IL10 and XIAP genes previously shown as correlated with IBD both in multifactorial and in Mendelian models. All variants identified are known in literature as being associated with IBD except for three variants in the genes NOD2, IL10 and IL10RB that even though present in online databases have never been involved in association studies on IBD patients. Moreover, we coupled genetic variants identification with an accurate "in silico" analysis to verify their predictive impact on the protein structure and function. The in-silico prediction of these variants results as benign therefore even if they exhibit a very low frequency in control population being benign, they cannot be considered pathogenic as monogenic disease but fall within the multifactorial range. The variants identified in our study partially reflect the association data described in the literature but there are no significant differences with the onset of disease (VEO vs EO-IBD).

%B Gene %V 645 %P 18-29 %8 2018 Mar 01 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29248579?dopt=Abstract %R 10.1016/j.gene.2017.12.029 %0 Journal Article %J Clin Immunol %D 2018 %T Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): Not only infections, but high risk of autoimmune complications. %A De Rose, Domenico Umberto %A Giliani, Silvia %A Notarangelo, Lucia Dora %A Lougaris, Vassilios %A Lanfranchi, Arnalda %A Moratto, Daniele %A Martire, Baldassarre %A Specchia, Fernando %A Tommasini, Alberto %A Plebani, Alessandro %A Badolato, Raffaele %X

Leukocyte Adhesion Deficiency type 1 (LAD-1) is a rare primary immunodeficiency due to mutations in the gene encoding for the common β-chain of the β2 integrin family (CD18). Herein, we describe clinical manifestations and long-term complications of eight LAD-1 patients. Four LAD-1 patients were treated with hematopoietic stem cell transplantation (HSCT), while the remaining four, including two with moderate LAD-1 deficiency, received continuous antibiotic prophylaxis. Untreated patients presented numerous infections and autoimmune manifestations. In particular, two of them developed renal and intestinal autoimmune diseases, despite the expression of Beta-2 integrin was partially conserved. Other two LAD-1 patients developed type 1 diabetes and autoimmune cytopenia after HSCT, suggesting that HSCT is effective for preventing infections in LAD-1, but does not prevent the risk of the autoimmune complications.

%B Clin Immunol %V 191 %P 75-80 %8 2018 Jun %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29548898?dopt=Abstract %R 10.1016/j.clim.2018.03.005 %0 Journal Article %J Pediatr Int %D 2018 %T Low-dose sirolimus in two cousins with autoimmune lymphoproliferative syndrome-associated infection. %A Nocerino, Agostino %A Valencic, Erica %A Loganes, Claudia %A Pelos, Giorgio %A Tommasini, Alberto %K Anti-Bacterial Agents %K Autoimmune Lymphoproliferative Syndrome %K Child %K Child, Preschool %K Dose-Response Relationship, Drug %K Female %K Humans %K Immunosuppressive Agents %K Infant %K Male %K Otitis Media %K Pneumonia, Bacterial %K Sirolimus %B Pediatr Int %V 60 %P 315-317 %8 2018 Mar %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29480551?dopt=Abstract %R 10.1111/ped.13494 %0 Journal Article %J Int J Mol Sci %D 2018 %T Neuronal Dysfunction Associated with Cholesterol Deregulation. %A Marcuzzi, Annalisa %A Loganes, Claudia %A Valencic, Erica %A Piscianz, Elisa %A Monasta, Lorenzo %A Bilel, Sabrine %A Bortul, Roberta %A Celeghini, Claudio %A Zweyer, Marina %A Tommasini, Alberto %K Anticholesteremic Agents %K Cell Line, Tumor %K Cholesterol %K Electron Transport %K Humans %K Lovastatin %K Mitochondria %K Neurons %K Neuroprotective Agents %K Organophosphorus Compounds %K Ubiquinone %X

Cholesterol metabolism is crucial for cells and, in particular, its biosynthesis in the central nervous system occurs in situ, and its deregulation involves morphological changes that cause functional variations and trigger programmed cell death. The pathogenesis of rare diseases, such as Mevalonate Kinase Deficiency or Smith⁻Lemli⁻Opitz Syndrome, arises due to enzymatic defects in the cholesterol metabolic pathways, resulting in a shortage of downstream products. The most severe clinical manifestations of these diseases appear as neurological defects. Expanding the knowledge of this biological mechanism will be useful for identifying potential targets and preventing neuronal damage. Several studies have demonstrated that deregulation of the cholesterol pathway induces mitochondrial dysfunction as the result of respiratory chain damage. We set out to determine whether mitochondrial damage may be prevented by using protective mitochondria-targeted compounds, such as MitoQ, in a neuronal cell line treated with a statin to induce a biochemical block of the cholesterol pathway. Evidence from the literature suggests that mitochondria play a crucial role in the apoptotic mechanism secondary to blocking the cholesterol pathway. Our study shows that MitoQ, administered as a preventive agent, could counteract the cell damage induced by statins in the early stages, but its protective role fades over time.

%B Int J Mol Sci %V 19 %8 2018 May 19 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/29783748?dopt=Abstract %R 10.3390/ijms19051523 %0 Journal Article %J Basic Clin Pharmacol Toxicol %D 2018 %T Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease. %A Lucafò, Marianna %A Di Silvestre, Alessia %A Romano, Maurizio %A Avian, Alice %A Antonelli, Roberta %A Martelossi, Stefano %A Naviglio, Samuele %A Tommasini, Alberto %A Stocco, Gabriele %A Ventura, Alessandro %A Decorti, Giuliana %A De Iudicibus, Sara %K Biomarkers %K Cell Line, Tumor %K Cell Proliferation %K Child %K Drug Resistance %K Female %K Gene Knockdown Techniques %K Glucocorticoids %K Humans %K Inflammatory Bowel Diseases %K Male %K Patient Selection %K Pharmacogenomic Testing %K Precision Medicine %K RNA, Long Noncoding %K RNA, Small Interfering %K Treatment Outcome %K Up-Regulation %X

Glucocorticoids (GCs) are widely employed in inflammatory, autoimmune and neoplastic diseases, and, despite the introduction of novel therapies, remain the first-line treatment for inducing remission in inflammatory bowel disease (IBD). Given the high incidence of suboptimal response, associated with a significant number of side-effects, that are particularly severe in paediatric patients, the identification of subjects that are most likely to respond poorly to GCs is extremely important. Recent evidence suggests that the long non-coding RNA (lncRNA) GAS5 could be a potential marker of GC resistance. To address this issue, we evaluated the association between the lncRNA GAS5 and the efficacy of steroids, in terms of inhibition of proliferation, in two cell lines derived from colon and ovarian cancers, to confirm the sensitivity and specificity of these lncRNAs. These cells showed a different sensitivity to GCs and revealed differential expression of GAS5 after treatment. GAS5 was up-regulated in GC-resistant cells and accumulated more in the cytoplasm compared to the nucleus in response to the drug. The functions of GAS5 were assessed by silencing, and we found that GAS5 knock-down reduced the proliferation during GC treatment. Furthermore, for the first time, we measured GAS5 levels in 19 paediatric IBD patients at diagnosis and after the first cycle of GCs, and we demonstrated an up-regulation of the lncRNA in patients with unfavourable steroid response. Our preliminary results indicate that GAS5 could be considered a novel pharmacogenomic marker useful for the personalization of GC therapy.

%B Basic Clin Pharmacol Toxicol %V 122 %P 87-93 %8 2018 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/28722800?dopt=Abstract %R 10.1111/bcpt.12851 %0 Journal Article %J J Allergy Clin Immunol Pract %D 2018 %T Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency. %A Valencic, Erica %A Grasso, Antonio Giacomo %A Conversano, Ester %A Lucafò, Marianna %A Piscianz, Elisa %A Gregori, Massimo %A Conti, Francesca %A Cancrini, Caterina %A Tommasini, Alberto %B J Allergy Clin Immunol Pract %V 6 %P 2165-2167 %8 2018 Nov - Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/29510232?dopt=Abstract %R 10.1016/j.jaip.2018.02.029 %0 Journal Article %J Ann Rheum Dis %D 2017 %T ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. %A Caorsi, Roberta %A Penco, Federica %A Grossi, Alice %A Insalaco, Antonella %A Omenetti, Alessia %A Alessio, Maria %A Conti, Giovanni %A Marchetti, Federico %A Picco, Paolo %A Tommasini, Alberto %A Martino, Silvana %A Malattia, Clara %A Gallizi, Romina %A Podda, Rosa Anna %A Salis, Annalisa %A Falcini, Fernanda %A Schena, Francesca %A Garbarino, Francesca %A Morreale, Alessia %A Pardeo, Manuela %A Ventrici, Claudia %A Passarelli, Chiara %A Zhou, Qing %A Severino, Mariasavina %A Gandolfo, Carlo %A Damonte, Gianluca %A Martini, Alberto %A Ravelli, Angelo %A Aksentijevich, Ivona %A Ceccherini, Isabella %A Gattorno, Marco %K Adenosine Deaminase %K Adolescent %K Age of Onset %K Case-Control Studies %K Child %K Child, Preschool %K DNA Mutational Analysis %K Female %K Heterozygote %K Homozygote %K Humans %K Immunoglobulins %K Immunosuppressive Agents %K Infant %K Intercellular Signaling Peptides and Proteins %K Italy %K Livedo Reticularis %K Male %K Pedigree %K Polyarteritis Nodosa %K Stroke %K Thalidomide %K Tumor Necrosis Factor-alpha %K Young Adult %X

OBJECTIVES: To analyse the prevalence of mutations in patients diagnosed with early onset livedo reticularis and/or haemorrhagic/ischaemic strokes in the context of inflammation or polyarteritis nodosa (PAN). Forty-eight patients from 43 families were included in the study.

METHODS: Direct sequencing of was performed by Sanger analysis. Adenosine deaminase 2 (ADA2) enzymatic activity was analysed in monocyte isolated from patients and healthy controls incubated with adenosine and with or without an ADA1 inhibitor.

RESULTS: Biallelic homozygous or compound heterozygous mutations were detected in 15/48 patients. A heterozygous disease-associated mutation (p.G47V) was observed in two affected brothers. The mean age of onset of the genetically positive patients was 24 months (6 months to 7 years). Ten patients displayed one or more cerebral strokes during their disease course. Low immunoglobulin levels were detected in six patients. Thalidomide and anti-TNF (tumour necrosis factor) blockers were the most effective drugs. Patients without mutations had a later age at disease onset, a lower prevalence of neurological and skin manifestations; one of these patients displayed all the clinical features of adenosine deaminase 2deficiency (DADA2) and a defective enzymatic activity suggesting the presence of a missed mutation or a synthesis defect.

CONCLUSIONS: DADA2 accounts for paediatric patients diagnosed with PAN-like disease and strokes and might explain an unrecognised condition in patients followed by adult rheumatologist. Timely diagnosis and treatment with anti-TNF agents are crucial for the prevention of severe complications of the disease. Functional assay to measure ADA2 activity should complement genetic testing in patients with non-confirming genotypes.

%B Ann Rheum Dis %V 76 %P 1648-1656 %8 2017 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/28522451?dopt=Abstract %R 10.1136/annrheumdis-2016-210802 %0 Journal Article %J Nutrients %D 2017 %T Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage. %A Loganes, Claudia %A Lega, Sara %A Bramuzzo, Matteo %A Vecchi Brumatti, Liza %A Piscianz, Elisa %A Valencic, Erica %A Tommasini, Alberto %A Marcuzzi, Annalisa %K Anti-Inflammatory Agents, Non-Steroidal %K Apoptosis %K Cell Survival %K Curcuma %K Curcumin %K Cytokines %K Epithelial Cells %K HT29 Cells %K Humans %K Inflammation %K Interferon-gamma %K Interleukin-7 %K Intestinal Mucosa %K NF-kappa B %K Phosphorylation %K Signal Transduction %X

The purpose of this study is to determine if a preventive treatment with curcumin can protect intestinal epithelial cells from inflammatory damage induced by IFNγ. To achieve this goal we have used a human intestinal epithelial cell line (HT29) treated with IFNγ to undergo apoptotic changes that can reproduce the damage of intestinal epithelia exposed to inflammatory cytokines. In this model, we measured the effect of curcumin (curcuminoid from ) added as a pre-treatment at different time intervals before stimulation with IFNγ. Curcumin administration to HT29 culture before the inflammatory stimulus IFNγ reduced the cell apoptosis rate. This effect gradually declined with the reduction of the curcumin pre-incubation time. This anti-apoptotic action by curcumin pre-treatment was paralleled by a reduction of secreted IL7 in the HT29 culture media, while there was no relevant change in the other cytokine levels. Even though curcumin pre-administration did not impact the activation of the NF-κB pathway, a slight effect on the phosphorylation of proteins in this inflammatory signaling pathway was observed. In conclusion, curcumin pre-treatment can protect intestinal cells from inflammatory damage. These results can be the basis for studying the preventive role of curcumin in inflammatory bowel diseases.

%B Nutrients %V 9 %8 2017 Jun 06 %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/28587282?dopt=Abstract %R 10.3390/nu9060578 %0 Journal Article %J Clin Rheumatol %D 2017 %T Describing Kawasaki shock syndrome: results from a retrospective study and literature review. %A Taddio, Andrea %A Rossi, Eleonora Dei %A Monasta, Lorenzo %A Pastore, Serena %A Tommasini, Alberto %A Lepore, Loredana %A Bronzetti, Gabriele %A Marrani, Edoardo %A Mottolese, Biancamaria D'Agata %A Simonini, Gabriele %A Cimaz, Rolando %A Ventura, Alessandro %K C-Reactive Protein %K Child %K Child, Preschool %K Echocardiography %K Female %K Heart Failure %K Hemoglobins %K Humans %K Immunoglobulins, Intravenous %K Male %K Mucocutaneous Lymph Node Syndrome %K Retrospective Studies %K Shock %K Syndrome %X

Kawasaki shock syndrome (KSS) is a rare manifestation of Kawasaki disease (KD) characterized by systolic hypotension or clinical signs of poor perfusion. The objectives of the study are to describe the main clinical presentation, echocardiographic, and laboratory findings, as well as the treatment options and clinical outcomes of KSS patients when compared with KD patients. This is a retrospective study. All children referred to two pediatric rheumatology units from January 1, 2012, to December 31, 2014, were enrolled. Patients were divided into patients with or without KSS. We compared the two groups according to the following variables: sex, age, type of KD (classic, with less frequent manifestations, or incomplete), clinical manifestations, cardiac involvement, laboratory findings, therapy administered, response to treatment, and outcome. Eighty-four patients with KD were enrolled. Of these, five (6 %) met the criteria for KSS. Patients with KSS had higher values of C-reactive protein (p = 0.005), lower hemoglobin levels (p = 0.003); more frequent hyponatremia (p = 0.004), hypoalbuminemia (p = 0.004), and coagulopathy (p = 0.003); and increase in cardiac troponins (p = 0.000). Among the KSS patients, three had a coronary artery involvement, but none developed a permanent aneurysm. Intravenous immunoglobulin resistance was more frequent in the KSS group, although not significantly so (3/5, 60 % vs. 23/79, 30 %, P = NS). None of the five cases was fatal, and all recovered without sequelae. KSS patients are more likely to have higher rates of cardiac involvement. However, most cardiovascular abnormalities resolved promptly with therapy.

%B Clin Rheumatol %V 36 %P 223-228 %8 2017 Jan %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27230223?dopt=Abstract %R 10.1007/s10067-016-3316-8 %0 Journal Article %J Mol Med Rep %D 2016 %T Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes. %A Piscianz, Elisa %A Candilera, Vanessa %A Valencic, Erica %A Loganes, Claudia %A Paron, Greta %A De Iudicibus, Sara %A Decorti, Giuliana %A Tommasini, Alberto %X

Chronic inflammation associated with autoimmune activation is characteristic of rheumatic diseases from childhood to adulthood. In recent decades, significant improvements in the treatment of these types of disease have been achieved using disease modifying anti-rheumatic drugs (DMARDs), such as methotrexate (MTX) and, more recently, using biologic inhibitors. The recent introduction of kinase inhibitors (for example, tofacitinib; Tofa) further increases the available ARDs. However, there are patients that do not respond to any treatment strategies, for whom combination therapies are proposed. The data regarding the combined action of different drugs is lacking and the knowledge of the mechanisms of ARDs and their actions upon pathogenic lymphocytes, which are hypothesized to sustain disease, is poor. An in vitro model of inflammation was developed in the current study, in which stimulated and unstimulated lymphocytes were cultured together, but tracked separately, to investigate the action of MTX and Tofa on the two populations. By analysing lymphocyte proliferation and activation, and cytokine secretion in the culture supernatants, it was established that, due to the presence of activated cells, unstimulated cells underwent a bystander activation that was modulated by the ARDs. Additionally, varying administration schedules were demonstrated to affect lymphocytes differently in vitro, either directly or via bystander activation. Furthermore, MTX and Tofa exerted different effects; while MTX showed an antiproliferative effect, Tofa marginally effected activation, although only a slight antiproliferative action, which could be potentiated by sequential treatment with MTX. Thus, it was hypothesized that these differences may be exploited in sequential therapeutic strategies, to maximize the anti‑rheumatic effect. These findings are notable and must be accounted for, as bystander‑activated cells in vivo could contribute to the spread of autoimmune activation and disease progression.

%B Mol Med Rep %V 14 %P 574-82 %8 2016 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/27175898?dopt=Abstract %R 10.3892/mmr.2016.5263 %0 Journal Article %J Blood Cells Mol Dis %D 2016 %T Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis. %A Abate, Maria Valentina %A Stocco, Gabriele %A Devescovi, Raffaella %A Carrozzi, Marco %A Pierobon, Chiara %A Valencic, Erica %A Lucafò, Marianna %A Di Silvestre, Alessia %A d'Adamo, Pio %A Tommasini, Alberto %A Decorti, Giuliana %A Ventura, Alessandro %B Blood Cells Mol Dis %V 59 %P 97-9 %8 2016 Jul %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/27282575?dopt=Abstract %R 10.1016/j.bcmd.2016.05.001 %0 Journal Article %J J Rheumatol %D 2016 %T Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study. %A Naselli, Aldo %A Penco, Federica %A Cantarini, Luca %A Insalaco, Antonella %A Alessio, Mariolina %A Tommasini, Alberto %A Maggio, Cristina %A Obici, Laura %A Gallizi, Romina %A Cimmino, Marco %A Signa, Sara %A Lucherini, Orso Maria %A Carta, Sonia %A Caroli, Francesco %A Martini, Alberto %A Rubartelli, Anna %A Ceccherini, Isabella %A Gattorno, Marco %X

OBJECTIVE: The aim of our study was to analyze the clinical and functional effect of the p.Q703K (p. Q705K, c. 2107C>A) variant of the NLRP3 gene in a population of patients screened for suspected cryopyrin-associated periodic syndrome (CAPS).

METHODS: Since 2002, 580 patients underwent molecular analysis for NLRP3. Data on clinical presentation, response to treatment, and longterm followup were collected using a uniform questionnaire. The pattern of cytokine secretion after lipopolysaccharide stimulation from isolated monocytes was analyzed in 3 patients carrying the p.Q703K variant and 1 patient with a chronic infantile neurologic, cutaneous, articular syndrome phenotype carrying both the p.M406I and p.Q703K, and compared with 7 patients with CAPS with sure pathogenic variants and 6 healthy controls.

RESULTS: The p.Q703K variant was found in 57 screened patients with an overall allelic frequency of 5%. The frequency in normal controls was 5.5%. Clinical data at the moment of molecular analysis and at followup were available in 36 patients. Two patients displayed additional mutations of NLRP3. The mean followup was 2.5 years. Thirteen patients (39%) had a final diagnosis different from the original suspicion of CAPS. The remaining 21 patients displayed a mild phenotype mainly characterized by recurrent episodes of urticarial rash and arthralgia. Only 8 patients were treated with anti-interleukin (IL)-1 treatment, with a complete response in 5 patients. The pattern of secretion of IL-1β and other cytokines (IL-6 and IL-1 receptor antagonist) in patients did not display the aberrancies observed in patients with CAPS and was similar to that observed in healthy controls.

CONCLUSION: The present study confirms the weak clinical and functional effect of the p.Q703K variant.

%B J Rheumatol %V 43 %P 1093-100 %8 2016 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/27036377?dopt=Abstract %R 10.3899/jrheum.150962 %0 Journal Article %J Clin Exp Pharmacol Physiol %D 2016 %T Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance. %A Lucafò, Marianna %A Bravin, Vanessa %A Tommasini, Alberto %A Martelossi, Stefano %A Rabach, Ingrid %A Ventura, Alessandro %A Decorti, Giuliana %A De Iudicibus, Sara %X

This study evaluates the association between the long noncoding RNA GAS5 levels and the anti-proliferative effect of the glucocorticoid (GC) methylprednisolone (MP) alone and in combination with rapamycin in peripheral blood mononuclear cells (PBMCs) obtained from healthy donors. The effect of MP, rapamycin, and MP plus rapamycin was determined in 17 healthy donors by labelling metabolically active cells with [methyl-3H] thymidine and the expression levels of GAS5 gene were evaluated by real-time RT-PCR TaqMan analysis. We confirmed a role for GAS5 in modulating GC response: poor responders presented higher levels of GAS5 in comparison with good responders. Interestingly, when PBMCs were treated with the combination of rapamycin plus MP, the high levels of GAS5 observed for each drug in the MP poor responders group decreased in comparison with rapamycin (P value = 0.0134) or MP alone (P value = 0.0193). GAS5 is involved in GC resistance and co-treatment of rapamycin with GCs restores GC effectiveness in poor responders through the downregulation of the long noncoding RNA. GAS5 could be considered a biomarker to personalize therapy and a novel therapeutic target useful for the development of new pharmacological approaches to restore GC sensitivity.

%B Clin Exp Pharmacol Physiol %V 43 %P 602-5 %8 2016 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/27001230?dopt=Abstract %R 10.1111/1440-1681.12572 %0 Journal Article %J Mol Med Rep %D 2016 %T Putative modifier genes in mevalonate kinase deficiency. %A Marcuzzi, Annalisa %A Vozzi, Diego %A Girardelli, Martina %A Tricarico, Paola Maura %A Knowles, Alessandra %A Crovella, Sergio %A Vuch, Josef %A Tommasini, Alberto %A Piscianz, Elisa %A Bianco, Anna Monica %X

Mevalonate kinase deficiency (MKD) is an autosomal recessive auto‑inflammatory disease, caused by impairment of the mevalonate pathway. Although the molecular mechanism remains to be elucidated, there is clinical evidence suggesting that other regulatory genes may be involved in determining the phenotype. The identification of novel target genes may explain non‑homogeneous genotype‑phenotype correlations, and provide evidence in support of the hypothesis that novel regulatory genes predispose or amplify deregulation of the mevalonate pathway in this orphan disease. In the present study, DNA samples were obtained from five patients with MKD, which were then analyzed using whole exome sequencing. A missense variation in the PEX11γ gene was observed in homozygosis in P2, possibly correlating with visual blurring. The UNG rare gene variant was detected in homozygosis in P5, without correlating with a specific clinical phenotype. A number of other variants were found in the five analyzed DNA samples from the MKD patients, however no correlation with the phenotype was established. The results of the presents study suggested that further analysis, using next generation sequencing approaches, is required on a larger sample size of patients with MKD, who share the same MVK mutations and exhibit 'extreme' clinical phenotypes. As MVK mutations may be associated with MKD, the identification of specific modifier genes may assist in providing an earlier diagnosis.

%B Mol Med Rep %V 13 %P 3181-9 %8 2016 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26935981?dopt=Abstract %R 10.3892/mmr.2016.4918 %0 Journal Article %J Clin Immunol %D 2015 %T Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. %A Lougaris, Vassilios %A Faletra, Flavio %A Lanzi, Gaetana %A Vozzi, Diego %A Marcuzzi, Annalisa %A Valencic, Erica %A Piscianz, Elisa %A Bianco, AnnaMonica %A Girardelli, Martina %A Baronio, Manuela %A Loganes, Claudia %A Fasth, Anders %A Salvini, Filippo %A Trizzino, Antonino %A Moratto, Daniele %A Facchetti, Fabio %A Giliani, Silvia %A Plebani, Alessandro %A Tommasini, Alberto %K B-Lymphocytes %K Child, Preschool %K Female %K Germinal Center %K Humans %K Hyper-IgM Immunodeficiency Syndrome %K Infant %K Male %K Mutation %K Phenotype %K Phosphatidylinositol 3-Kinases %K RNA Splice Sites %K Sequence Analysis, DNA %B Clin Immunol %V 159 %P 33-6 %8 2015 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/25939554?dopt=Abstract %R 10.1016/j.clim.2015.04.014 %0 Journal Article %J Clin Exp Rheumatol %D 2015 %T Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy. %A Paloni, Giulia %A Pastore, Serena %A Tommasini, Alberto %A Lepore, Loredana %A Taddio, Andrea %K Antibodies, Monoclonal %K Carrier Proteins %K Cryopyrin-Associated Periodic Syndromes %K Drug Administration Schedule %K Female %K Genetic Predisposition to Disease %K Humans %K Immunosuppressive Agents %K Interleukin 1 Receptor Antagonist Protein %K Interleukin-1beta %K Mosaicism %K Phenotype %K Recurrence %K Remission Induction %K Time Factors %K Treatment Outcome %K Young Adult %B Clin Exp Rheumatol %V 33 %P 766 %8 2015 Sep-Oct %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/26316056?dopt=Abstract %0 Journal Article %J BMC Pediatr %D 2015 %T The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency. %A Girardelli, Martina %A Arrigo, Serena %A Barabino, Arrigo %A Loganes, Claudia %A Morreale, Giuseppe %A Crovella, Sergio %A Tommasini, Alberto %A Bianco, Anna Monica %X

BACKGROUND: Aggressive course and resistance to treatments usually characterize very early onset inflammatory bowel disease (VEO-IBD). Some VEO-IBD cases are due to monogenic immune defects and can benefit from hematopoietic stem cell transplantation (HSCT).

CASE PRESENTATION: We describe a Caucasian male baby who presented in the first months of life macrophage activation syndrome, followed by intractable colitis, recurrent episodes of fever and mild splenomegaly. After several immunological, genetic and clinical investigations, subsequently a therapeutic attempt with colectomy, analysis of VEO-IBD-associated genes, revealed a causative mutation in XIAP. The genetic diagnosis of a primary immune deficiency allowed curing the boy with hematopoietic stem cell transplantation.

CONCLUSION: Our report, together with novel findings from recent literature, should contribute to increase awareness of monogenic immune defects as a cause of VEO-IBD. Comprehensive genetic analysis can allow a prompt diagnosis, resulting in the choice of effective treatments and sparing useless and damaging procedures.

%B BMC Pediatr %V 15 %P 208 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26671016?dopt=Abstract %R 10.1186/s12887-015-0522-5 %0 Journal Article %J Clin Exp Rheumatol %D 2015 %T Different presentations of mevalonate kinase deficiency: a case series. %A De Pieri, Carlo %A Taddio, Andrea %A Insalaco, Antonella %A Barbi, Egidio %A Lepore, Loredana %A Ventura, Alessandro %A Tommasini, Alberto %K Age Factors %K Bacterial Infections %K Child %K Child, Preschool %K Diagnosis, Differential %K Diagnostic Errors %K Female %K Genetic Predisposition to Disease %K Humans %K Infant %K Inflammatory Bowel Diseases %K Male %K Mevalonate Kinase Deficiency %K Phenotype %K Predictive Value of Tests %K Recurrence %K Risk Factors %K Sepsis %K Vasculitis %K Young Adult %X

OBJECTIVES: We aimed to raise awareness among paediatricians and physicians about this often misunderstood condition.

METHODS: We discussed the clinical profiles associated with late or wrong diagnosis of mevalonate kinase deficency (MKD) in a single centre case series.

RESULTS: We analysed the most common challenges and pitfalls that a clinician might face during the diagnostic process. Five main clinical profiles were characterised.

CONCLUSIONS: We propose a new perspective on MKD, suggesting that the presentation of this disease can vary from patient to patient.

%B Clin Exp Rheumatol %V 33 %P 437-42 %8 2015 May-Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/25897835?dopt=Abstract %0 Journal Article %J World J Gastroenterol %D 2015 %T Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease. %A Taddio, Andrea %A Tommasini, Alberto %A Valencic, Erica %A Biagi, Ettore %A Decorti, Giuliana %A De Iudicibus, Sara %A Cuzzoni, Eva %A Gaipa, Giuseppe %A Badolato, Raffaela %A Prandini, Alberto %A Biondi, Andrea %A Ventura, Alessandro %X

Mesenchymal stem cells (MSC) are cells of stromal origin which exhibit unlimited self-renewal capacity and pluripotency in vitro. It has recently been observed that MSC may also exert a profound immunosuppressive and anti-inflammatory effect both in vitro and in vivo with consequent potential use in autoimmune disorders. We present the case of a patient suffering from childhood-onset, multidrug resistant and steroid-dependent Crohn's disease who underwent systemic infusions of MSC, which led to a temporary reduction in CCR4, CCR7 and CXCR4 expression by T-cells, and a temporary decrease in switched memory B-cells, In addition, following MSC infusion, lower doses of steroids were needed to inhibit proliferation of the patient's peripheral blood mononuclear cells. Despite these changes, no significant clinical benefit was observed, and the patient required rescue therapy with infliximab and subsequent autologous hematopoietic stem cell transplantation. The results of biological and in vitro observations after MSC use and the clinical effects of infusion are discussed, and a brief description is provided of previous data on MSC-based therapy in autoimmune disorders.

%B World J Gastroenterol %V 21 %P 4379-84 %8 2015 Apr 14 %G eng %N 14 %1 http://www.ncbi.nlm.nih.gov/pubmed/25892890?dopt=Abstract %R 10.3748/wjg.v21.i14.4379 %0 Journal Article %J World J Clin Pediatr %D 2015 %T Fever tree revisited: From malaria to autoinflammatory diseases. %A Pastore, Serena %A Vuch, Josef %A Bianco, Anna Monica %A Taddio, Andrea %A Tommasini, Alberto %X

Over the centuries the idea of recurrent fevers has mainly been associated with malaria, but many other fevers, such as typhoid and diphtheria were cause for concern. It is only in recent times, with the more severe forms of fever from infectious origin becoming less frequent or a cause for worry that we started noticing recurrent fevers without any clear infectious cause, being described as having a pathogenesis of autoinflammatory nature. The use of molecular examinations in many cases can allow a diagnosis where the cause is monogenic. In other cases, however the pathogenesis is likely to be multifactorial and the diagnostic-therapeutic approach is strictly clinical. The old fever tree paradigm developed to describe fevers caused by malaria has been revisited here to describe today's periodic fevers from the periodic fever adenitis pharyngitis aphthae syndrome to the more rare autoinflammatory diseases. This model may allow us to place cases that are yet to be identified which are likely to be of multifactorial origin.

%B World J Clin Pediatr %V 4 %P 106-12 %8 2015 Nov 8 %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26566482?dopt=Abstract %R 10.5409/wjcp.v4.i4.106 %0 Journal Article %J Pediatr Rheumatol Online J %D 2015 %T Genetic profiling of autoinflammatory disorders in patients with periodic fever: a prospective study. %A De Pieri, Carlo %A Vuch, Josef %A De Martino, Eleonora %A Bianco, Anna M %A Ronfani, Luca %A Athanasakis, Emmanouil %A Bortot, Barbara %A Crovella, Sergio %A Taddio, Andrea %A Severini, Giovanni M %A Tommasini, Alberto %K Adolescent %K Carrier Proteins %K Child %K Cryopyrin-Associated Periodic Syndromes %K Cytoskeletal Proteins %K Familial Mediterranean Fever %K Female %K Fever %K Gene Expression Profiling %K Genotype %K Hereditary Autoinflammatory Diseases %K Humans %K Intracellular Signaling Peptides and Proteins %K Logistic Models %K Male %K Mutation %K Phosphotransferases (Alcohol Group Acceptor) %K Prospective Studies %K Receptors, Tumor Necrosis Factor, Type I %K Syndrome %X

BACKGROUND: Periodic fever syndromes (PFS) are an emerging group of autoinflammatory disorders. Clinical overlap exists and multiple genetic analyses may be needed to assist diagnosis. We evaluated the diagnostic value of a 5-gene sequencing panel (5GP) in patients with undiagnosed PFS.

METHODS: Simultaneous double strand Sanger sequencing of MEFV, MVK, TNFRSF1A, NLRP3, NLRP12 genes was performed in 42 patients with unexplained PFS. Clinical features were correlated with genetic results.

RESULTS: None of 42 patients analyzed displayed a causative genotype. However, single or multiple genetic variants of uncertain significance were detected in 24 subjects. Only in 5 subjects a definite diagnosis was made by taking into account both genetic and clinical data (2 TRAPS syndrome; 2 FMF; 1 FCAS). Statistical analysis showed that patients carrying genetic variants in one or more of the five selected genes displayed a significantly lower response to glucocorticoids compared with subjects who had completely negative genetic results.

CONCLUSIONS: The sequencing of multiple genes is of little help in the diagnostics of PFS and can often lead to results of uncertain interpretation, thus the clinically driven sequencing of single genes should remain the recommended approach. However, the presence of single or multiple genetic variants of uncertain significance, even if not allowing any specific diagnosis, correlated with a poorer response to glucocorticoids, possibly indicating a multifactorial subgroup of PFS with differential response to pharmacological treatment.

%B Pediatr Rheumatol Online J %V 13 %P 11 %8 2015 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/25866490?dopt=Abstract %R 10.1186/s12969-015-0006-z %0 Journal Article %J World J Gastroenterol %D 2015 %T Genetics of inflammatory bowel disease from multifactorial to monogenic forms. %A Bianco, Anna Monica %A Girardelli, Martina %A Tommasini, Alberto %X

Inflammatory bowel disease (IBD) is a group of chronic multifactorial disorders. According to a recent study, the number of IBD association loci is increased to 201, of which 37 and 27 loci contribute specifically to the development of Crohn's disease and ulcerative colitis respectively. Some IBD associated genes are involved in innate immunity, in the autophagy and in the inflammatory response such as NOD2, ATG16L1 and IL23R, while other are implicated in immune mediated disease (STAT3) and in susceptibility to mycobacterium infection (IL12B). In case of early onset of IBD (VEO-IBD) within the 6(th) year of age, the disease may be caused by mutations in genes responsible for severe monogenic disorders such as the primary immunodeficiency diseases. In this review we discuss how these monogenic disorders through different immune mechanisms can similarly be responsible of VEO-IBD phenotype. Moreover we would highlight how the identification of pathogenic genes by Next Generation Sequencing technologies can allow to obtain a rapid diagnosis and to apply specific therapies.

%B World J Gastroenterol %V 21 %P 12296-310 %8 2015 Nov 21 %G eng %N 43 %1 http://www.ncbi.nlm.nih.gov/pubmed/26604638?dopt=Abstract %R 10.3748/wjg.v21.i43.12296 %0 Journal Article %J Ann Rheum Dis %D 2015 %T Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. %A Rusmini, Marta %A Federici, Silvia %A Caroli, Francesco %A Grossi, Alice %A Baldi, Maurizia %A Obici, Laura %A Insalaco, Antonella %A Tommasini, Alberto %A Caorsi, Roberta %A Gallo, Eleonora %A Olivieri, Alma Nunzia %A Marzano, AngeloValerio %A Coviello, Domenico %A Ravazzolo, Roberto %A Martini, Alberto %A Gattorno, Marco %A Ceccherini, Isabella %X

OBJECTIVES: Systemic auto-inflammatory disorders (SAIDs) are a heterogeneous group of monogenic diseases sharing a primary dysfunction of the innate immune system. More than 50% of patients with SAID does not show any mutation at gene(s) tested because of lack of precise clinical classification criteria and/or incomplete gene screening. To improve the molecular diagnosis and genotype interpretation of SAIDs, we undertook the development of a next-generation sequencing (NGS)-based protocol designed to simultaneous screening of 10 genes.

METHODS: Fifty patients with SAID, already genotyped for the respective causative gene(s), were massively sequenced for the coding portions of MEFV, MVK, TNFRSF1A, NLRP3, NLRP12, NOD2, PSTPIP1, IL1RN, LPIN2 and PSMB8. Three different bioinformatic pipelines (Ion Reporter, CLC Bio Genomics Workbench, GATK-based in-house workflow) were compared.

RESULTS: Once resulting variants were compared with the expected mutation list, no workflow turned out to be able to detect all the 79 variants known in the 50 DNAs. Additional variants were also detected, validated by Sanger sequencing and compared to assess true and false positive detection rates of the three workflows. Finally, the overall clinical picture of 34 patients was re-evaluated in the light of the new mutations found.

CONCLUSIONS: The present gene panel has resulted suitable for molecular diagnosis of SAIDs. Moreover, genotype-phenotype correlation has confirmed that the interpretation of NGS data in patients with an undefined inflammatory phenotype is remarkably difficult, thus supporting the need of evidence-based and validated clinical criteria to be used concurrently with the genetic analysis for the final diagnosis and classification of patients with SAIDs.

%B Ann Rheum Dis %8 2015 Sep 17 %G ENG %1 http://www.ncbi.nlm.nih.gov/pubmed/26386126?dopt=Abstract %R 10.1136/annrheumdis-2015-207701 %0 Journal Article %J Curr Drug Metab %D 2015 %T Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? %A Stocco, Gabriele %A Lanzi, Gaetana %A Yue, Fengming %A Giliani, Silvia %A Sasaki, Katsunori %A Tommasini, Alberto %A Pelin, Marco %A Martelossi, Stefano %A Ventura, Alessandro %A Decorti, Giuliana %X

Induced pluripotent stem cells (iPSC) can be produced from adult cells by transfecting them with a definite set of pluripotency-associated genes. Under adequate growth conditions and stimulation iPSC can differentiate to almost every somatic lineage in the body. Patients' derived iPSC are an innovative model to study mechanisms of adverse drug reactions in individual patients and in cell types that cannot be easily obtained from human subjects. Proof-of concept studies with known toxicants have been performed for liver, cardiovascular and central nervous system cells: neurons obtained from iPSC have been used to elucidate the mechanism of chemotherapy-induced peripheral neuropathy by evaluating the effects of neurotoxic drugs such as vincristine. However, no study has been performed yet on pancreatic tissue and drug induced pancreatitis. Thiopurines (azathioprine and mercaptopurine) are immunosuppressive antimetabolite drugs, commonly used to treat Crohn's disease. About 5% of Crohn's disease patients treated with thiopurines develop pancreatitis, a severe idiosyncratic adverse event; these patients have to stop thiopurine administration and may require medical treatment, with significant personal and social costs. Molecular mechanism of thiopurine induced pancreatitis (TIP) is currently unknown and no fully validated biomarker is available to assist clinicians in preventing this adverse event. Hence, in this review we have reflected upon the probable research applications of exocrine pancreatic cells generated from patient specific iPS cells. Such pancreatic cells can provide excellent insights into the molecular mechanism of TIP. In particular three hypotheses on the mechanism of TIP could be explored: drug biotransformation, innate immunity and adaptative immunity.

%B Curr Drug Metab %V 17 %P 91-8 %8 2015 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/26526832?dopt=Abstract %0 Journal Article %J Int J Mol Sci %D 2015 %T To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies. %A Marcuzzi, Annalisa %A Piscianz, Elisa %A Valencic, Erica %A Monasta, Lorenzo %A Vecchi Brumatti, Liza %A Tommasini, Alberto %X

Cytokines are the most important soluble mediators of inflammation. Rare pediatric diseases provided exemplar conditions to study the anti-inflammatory efficacy of new generation therapies (biologics/biopharmaceuticals) selectively targeting single cytokines. Monoclonal antibodies and recombinant proteins have revolutionized anti-inflammatory therapies in the last two decades, allowing the specific targeting of single cytokines. They are very effective in extinguishing inflammation from outside the cell, even with the risk of an excessive and prolonged immunosuppression. Small molecules can enter the cell and shutdown the valve of inflammation by directly targeting signal proteins involved in cytokine release or in response to cytokines. They are orally-administrable drugs whose dosage can be easily adjusted to obtain the desired anti-inflammatory effect. This could make these drugs more suitable for a wide range of diseases as stroke, gout, or neurological impairment, where inflammatory activation plays a pivotal role as trigger. Autoinflammatory diseases, which have previously put anti-cytokine proteins in the limelight, can again provide a valuable model to measure the real potential of small inhibitors as anti-inflammatory agents.

%B Int J Mol Sci %V 16 %P 21277-93 %8 2015 %G eng %N 9 %1 http://www.ncbi.nlm.nih.gov/pubmed/26370962?dopt=Abstract %R 10.3390/ijms160921277 %0 Journal Article %J Mol Med Rep %D 2015 %T Two‑gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. %A Bianco, Anna Monica %A Faletra, Flavio %A Vozzi, Diego %A Girardelli, Martina %A Knowles, Alessandra %A Tommasini, Alberto %A Zauli, Giorgio %A Marcuzzi, Annalisa %X

Next-generation sequencing (NGS) has generated a large amount of sequence data with the requirement of frequent critical revisions of reported mutations. This innovative tool has proved to be effective in detecting pathogenic mutations; however, it requires a certain degree of experience to identify incidental findings. In the present study, whole exome sequencing analysis was performed for the molecular diagnosis and correct genotype/phenotype correlation between parents and a patient presenting with an atypical phenotype. In addition, mevalonic acid quantification and frequency analysis of detected variants in public databases and X‑chromosome inactivation (XCI) studies on the patient's mother were performed. V377I as well as the S135L mutations were identified on the mevalonate kinase deficiency gene and the levels of mevalonic acid in the patient were 5,496 µg/ml. A D59G variation, reported in ESP6500 in two healthy individuals, was found on the Martin Probst syndrome gene (RAB40AL). Based on XCI studies on the patient's mother, it is likely that RAB40AL escapes XCI, while still remaining balanced. In conclusion, the results of the present study indicated that the Martin Probst syndrome is an X‑linked condition, which is probably not caused by RAB40AL mutations. Although NGS is a powerful tool to identify pathogenic mutations, the analysis of genetic data requires expert critical revision of all detected variants.

%B Mol Med Rep %V 12 %P 6128-32 %8 2015 Oct %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/26300074?dopt=Abstract %R 10.3892/mmr.2015.4215 %0 Journal Article %J Acta Histochem %D 2015 %T Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. %A Frausin, Stefano %A Viventi, Serena %A Verga Falzacappa, Lucia %A Quattromani, Miriana Jlenia %A Leanza, Giampiero %A Tommasini, Alberto %A Valencic, Erica %X

Multipotent mesenchymal stromal cells, also known as mesenchymal stem cells (MSC), can be isolated from bone marrow or other tissues, including fat, muscle and umbilical cord. It has been shown that MSC behave in vitro as stem cells: they self-renew and are able to differentiate into mature cells typical of several mesenchymal tissues. Moreover, the differentiation toward non-mesenchymal cell lineages (e.g. neurons) has been reported as well. The clinical relevance of these cells is mainly related to their ability to spontaneously migrate to the site of inflammation/damage, to their safety profile thanks to their low immunogenicity and to their immunomodulation capacities. To date, MSCs isolated from the post-natal bone marrow have represented the most extensively studied population of adult MSCs, in view of their possible use in various therapeutical applications. However, the bone marrow-derived MSCs exhibit a series of limitations, mainly related to their problematic isolation, culturing and use. In recent years, umbilical cord (UC) matrix (i.e. Wharton's jelly, WJ) stromal cells have therefore emerged as a more suitable alternative source of MSCs, thanks to their primitive nature and the easy isolation without relevant ethical concerns. This review seeks to provide an overview of the main biological properties of WJ-derived MSCs. Moreover, the potential application of these cells for the treatment of some known dysfunctions in the central and peripheral nervous system will also be discussed.

%B Acta Histochem %V 117 %P 329-38 %8 2015 May-Jun %G eng %N 4-5 %1 http://www.ncbi.nlm.nih.gov/pubmed/25747736?dopt=Abstract %R 10.1016/j.acthis.2015.02.005 %0 Journal Article %J Arch Dis Child %D 2014 %T Clinical significance of hyper-IgA in a paediatric laboratory series. %A Copetti, Valentina %A Pastore, Serena %A De Pieri, Carlo %A Radillo, Oriano %A Taddio, Andrea %A Ventura, Alessandro %A Tommasini, Alberto %K Adolescent %K Child %K Child, Preschool %K Female %K Hospitals, Pediatric %K Humans %K Hypergammaglobulinemia %K Immunoglobulin A %K Infant %K Italy %K Male %K Tertiary Care Centers %X

The causes of extremely elevated IgA, whether isolated or associated with an increase in other classes of immunoglobulin, are poorly defined in paediatrics. We reviewed the diagnostic significance of very high IgA levels (greater than 3 SD above the mean for age) in a cohort of patients referred to a tertiary care children's hospital. Hyper-IgA was found in 91 of 6364 subjects (1.4%) and in 68 cases was not associated with an increased IgG and/or IgM level. Most subjects with hyper-IgA (73.5%) had a severe immune defect, a chronic rheumatic disease or inflammatory bowel disease, while these conditions were very rare in a control group with normal IgA values (8%). Although our results may in part reflect the experience of a tertiary care centre, we suggest that hyper-IgA in children should always arouse suspicion of a serious disease.

%B Arch Dis Child %V 99 %P 1114-6 %8 2014 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/25053738?dopt=Abstract %R 10.1136/archdischild-2014-306607 %0 Journal Article %J Clin Exp Rheumatol %D 2014 %T F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls. %A De Pieri, Carlo %A Vuch, Josef %A Athanasakis, Emmanouil %A Severini, Giovanni Maria %A Crovella, Sergio %A Bianco, Anna Monica %A Tommasini, Alberto %K Cryopyrin-Associated Periodic Syndromes %K Female %K Humans %K Intracellular Signaling Peptides and Proteins %K Male %K Mutation %B Clin Exp Rheumatol %V 32 %P 993-4 %8 2014 Nov-Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/25327218?dopt=Abstract %0 Journal Article %J PLoS One %D 2014 %T Fate of lymphocytes after withdrawal of tofacitinib treatment. %A Piscianz, Elisa %A Valencic, Erica %A Cuzzoni, Eva %A De Iudicibus, Sara %A De Lorenzo, Elisa %A Decorti, Giuliana %A Tommasini, Alberto %K Antigens, CD %K B-Lymphocytes %K CD4-Positive T-Lymphocytes %K CD8-Positive T-Lymphocytes %K Cell Proliferation %K Drug Administration Schedule %K Humans %K Janus Kinase 3 %K Killer Cells, Natural %K Lymphocyte Activation %K Lymphocyte Count %K Phytohemagglutinins %K Piperidines %K Primary Cell Culture %K Protein Kinase Inhibitors %K Pyrimidines %K Pyrroles %X

Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to its selective action on proliferating cells, Tofa can offer a way to block T cell activation, without toxic effects on resting cells. However, few studies have investigated the effects of Tofa on lymphocyte activation in vitro. Our aim was to study the action of Tofa on different lymphocyte subsets after in vitro stimulation and to track the behaviour of treated cells after interruption of the treatment. Peripheral blood lymphocytes were stimulated in vitro with mitogen and treated with two concentrations of Tofa. After a first period in culture, cells were washed and further incubated for an additional time. Lymphocyte subsets, activation phenotype and proliferation were assessed at the different time frames. As expected, Tofa was able to reduce the activation and proliferation of lymphocytes in the first four days of treatment. In addition the drug led to a relative decrease of Natural Killer, B cells and CD8 T cells compared to CD4 T cells. However, treated cells were still viable after the first period in culture and begun to proliferate, strikingly, in a dose dependent manner when the drug was removed from the environment by replacing the culture medium. This novel data does not necessarily predict a similar behaviour in vivo, but can warn about the clinical use of this drug when a discontinuation of treatment with Tofa is considered for any reason.

%B PLoS One %V 9 %P e85463 %8 2014 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24416411?dopt=Abstract %R 10.1371/journal.pone.0085463 %0 Journal Article %J J Pediatr Hematol Oncol %D 2014 %T Hemophagocytic lymphohistiocytosis in total parenteral nutrition dependent children: description of 5 cases and practical tips for management. %A Pastore, Serena %A Barbieri, Francesca %A Di Leo, Grazia %A Valencic, Erica %A Tommasini, Alberto %A Ventura, Alessandro %K Child, Preschool %K Fatty Acids %K Female %K Humans %K Infant %K Intestinal Diseases %K Lymphohistiocytosis, Hemophagocytic %K Male %K Parenteral Nutrition, Total %K Steroids %K Treatment Outcome %X

Although total parenteral nutrition (TPN) is mandatory in children with intestinal failure, this treatment is not risk free. The main complications of TPN include catheter-related sepsis, thrombosis, hepatic cholestasis and cirrhosis, metabolic bone disease, and, rarely, reactive hemophagocytic lymphohistiocytosis (HLH). The pathogenesis of HLH in patients with TPN is not known, although some authors hypothesized that it can result from the activation of macrophages because of "fat overload." We reported 5 cases of HLH that occurred in patients with 4 different underlying disorders, all requiring TPN for a long term. In our series, an underlying immunological defect or a serious infection (sepsis) can have triggered HLH. Therefore, it could be reasonable to hypothesize that besides TPN in itself, minor immune defects and infections may act together by overcoming a threshold of immune stimulation, which ultimately leads to HLH.

%B J Pediatr Hematol Oncol %V 36 %P e440-2 %8 2014 Oct %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/23823121?dopt=Abstract %R 10.1097/MPH.0b013e31829f381b %0 Journal Article %J Pediatr Blood Cancer %D 2014 %T In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords. %A Comar, Manola %A Delbue, Serena %A Zanotta, Nunzia %A Valencic, Erica %A Piscianz, Elisa %A Del Savio, Rossella %A Tesser, Alessandra %A Tommasini, Alberto %A Ferrante, Pasquale %K DNA, Viral %K Female %K Fetal Blood %K Humans %K JC Virus %K Male %K Mesenchymal Stromal Cells %K Polyomavirus Infections %K Simian virus 40 %K Tumor Virus Infections %X

BACKGROUND: Multipotent stromal cells are present in the Wharton's jelly matrix (WJSC) of the umbilical cord and can be used as an allogeneic source of cells to treat immunological disorders. Recently it was demonstrated that adult bone marrow (BM)-derived mesenchimal stromal cells (MSC) are susceptible to infection with viruses showing potential oncogenic properties, such as the polyomavirus JC (JCV). The aim of this study was to investigate the presence of human polyomaviruses (JCV, BK Virus-BKV, SV40, and Merkel cell polyomavirus-MCPyV) in WJSC, and explore the risk of infection.

PROCEDURE: MSC samples from 35 umbilical cords were investigated by quantitative Real Time PCRs for the presence of DNA sequences of JCV, BKV, SV40, and MCPyV.

RESULTS: JCV DNA was detected in 1/35 (2.8%) of MSC samples, while SV40 DNA was found in 3/35 (8.6%) of the examined samples. None of the samples showed sequences of BKV and MCPyV.

CONCLUSIONS: The present study demonstrates the in vivo ability of polyomaviruses to infect WJSC. Since the therapeutic approach with the WJSC has high potentiality and a more intensive use can be easily hypothesized, the need to develop consensus guidelines to detect rare viral infections in MSC is pressing.

%B Pediatr Blood Cancer %V 61 %P 1347-9 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24623583?dopt=Abstract %R 10.1002/pbc.24943 %0 Journal Article %J Stem Cell Res Ther %D 2014 %T Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. %A Valencic, Erica %A Loganes, Claudia %A Cesana, Stefania %A Piscianz, Elisa %A Gaipa, Giuseppe %A Biagi, Ettore %A Tommasini, Alberto %K CD4-Positive T-Lymphocytes %K CD8-Positive T-Lymphocytes %K Cell Proliferation %K Cell Survival %K Cells, Cultured %K Coculture Techniques %K Culture Media, Conditioned %K Cytokines %K Humans %K Killer Cells, Natural %K Lymphocyte Activation %K Mesenchymal Stromal Cells %X

INTRODUCTION: Despite having a proven immunosuppressive potential in vitro, human mesenchymal stromal cells (MSCs) are reported to display variable efficacy in vivo and, in fact, their proven benefit in the clinical practice is still limited and controversial.

METHODS: The interplay between clinical grade MSCs and pre-activated donor lymphocytes or selected lymphocyte subsets was studied in vitro. The kinetics of MSC growth and viability was evaluated by adhesion-dependent changes of culture plate impedance and biochemically by a colorimetric assay. Activation of natural killer (NK) cells was assessed as well, using a flow cytometry assay.

RESULTS: A strong inhibition of MSC growth was rapidly induced by the addition of pre-activated lymphocytes but not of resting lymphocytes. Inhibition seems not to be attributable to a single cell population, as similar results can be obtained by depleting NK cells or by using either selected CD4+ or CD8+ lymphocytes. In addition, conditioned medium (CM) from activated lymphocytes was able to inhibit MSC growth in a dose-dependent manner. Furthermore, licensing with IFN-γ partially protected MSCs from pre-activated lymphocytes but not from their CM. These results suggest an inhibitory role of lymphocyte-activation-derived substances. However, the identification of a single molecule responsible for MSC inhibition remained elusive, even if preliminary experiments showed that ATP and, to a lesser extent, TNF-α might play a role.

CONCLUSIONS: These results suggest that survival of MSCs can be affected by soluble mediators released by activated lymphocytes. Thus it can be hypothesized that MSC immunosuppressive action in vivo could be impaired by ongoing immune activation through the release of inflammatory mediators.

%B Stem Cell Res Ther %V 5 %P 3 %8 2014 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/24405828?dopt=Abstract %R 10.1186/scrt392 %0 Journal Article %J Int J Mol Sci %D 2014 %T Novel missense mutation in the NOD2 gene in a patient with early onset ulcerative colitis: causal or chance association? %A Girardelli, Martina %A Vuch, Josef %A Tommasini, Alberto %A Crovella, Sergio %A Bianco, Anna Monica %K Age of Onset %K Amino Acid Sequence %K Base Sequence %K Child %K Colitis, Ulcerative %K Crohn Disease %K DNA Mutational Analysis %K Genetic Predisposition to Disease %K Genotype %K Humans %K Interleukin-10 Receptor alpha Subunit %K Interleukin-10 Receptor beta Subunit %K Molecular Sequence Data %K Mutation, Missense %K Nod2 Signaling Adaptor Protein %K Polymorphism, Single Nucleotide %K Risk Factors %K Sequence Homology, Amino Acid %X

Deregulated immune response to gut microflora in genetically predisposed individuals is typical for inflammatory bowel diseases. It is reasonable to assume that genetic association with the disease will be more pronounced in subjects with early onset than adult onset. The nucleotide-binding oligomerization domain containing-2 gene, commonly involved in multifactorial risk of Crohn's disease, and interleukin 10 receptor genes, associated with rare forms of early onset inflammatory bowel diseases, were sequenced in an early onset patient. We identified a novel variant in the NOD2 gene (c.2857A > G p.K953E) and two already described missense variants in the IL10RA gene (S159G and G351R). The new NOD2 missense variant was examined in silico with two online bioinformatics tools to predict the potentially deleterious effects of the mutation. Although cumulative effect of these variations in the early onset of the disease can be only hypothesized, we demonstrated that family information and in silico studies can be used to predict association with the disease.

%B Int J Mol Sci %V 15 %P 3834-41 %8 2014 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24595243?dopt=Abstract %R 10.3390/ijms15033834 %0 Journal Article %J J Crohns Colitis %D 2014 %T Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. %A Naviglio, Samuele %A Arrigo, Serena %A Martelossi, Stefano %A Villanacci, Vincenzo %A Tommasini, Alberto %A Loganes, Claudia %A Fabretto, Antonella %A Vignola, Silvia %A Lonardi, Silvia %A Ventura, Alessandro %K Child, Preschool %K Colon %K Colonoscopy %K Female %K Humans %K Infant %K Inflammatory Bowel Diseases %K Loeys-Dietz Syndrome %K Male %K Signal Transduction %K Transforming Growth Factor beta %X

Transforming growth factor beta is a pleiotropic cytokine which plays a central role in the homeostasis of the immune system. A complex dysregulation of its signaling occurs in Loeys-Dietz syndrome, a monogenic disorder caused by mutations of transforming growth factor beta receptors type 1 or type 2, characterized by skeletal involvement, craniofacial abnormalities, and arterial tortuosity with a strong predisposition for aneurysm and dissection. In addition, several immunologic abnormalities have been described in these patients, including an increased risk of allergic disorders as well as eosinophilic gastrointestinal disorders. The occurrence of inflammatory bowel disorders has been also reported, but it is poorly documented. We describe two unrelated children with Loeys-Dietz syndrome affected by severe chronic inflammatory colitis appearing at an early age. The intestinal disease presented similar features in both patients, including a histopathological picture of non-eosinophilic chronic ulcerative colitis, striking elevation of inflammatory markers, and a distinctly severe clinical course leading to failure to thrive, with resistance to multiple immunosuppressive treatments. One of the patients also presented autoimmune thyroiditis. Our report confirms that chronic ulcerative colitis may be associated with Loeys-Dietz syndrome. This finding suggests that an alteration of transforming growth factor beta signaling may by itself predispose to inflammatory colitis in humans, and represent an invaluable model to understand inflammatory bowel diseases.

%B J Crohns Colitis %V 8 %P 770-4 %8 2014 Aug %G eng %N 8 %1 http://www.ncbi.nlm.nih.gov/pubmed/24486179?dopt=Abstract %R 10.1016/j.crohns.2014.01.013 %0 Journal Article %J Pharmacogenomics %D 2014 %T TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype. %A Franca, Raffaella %A Rebora, Paola %A Athanasakis, Emmanouil %A Favretto, Diego %A Verzegnassi, Federico %A Basso, Giuseppe %A Tommasini, Alberto %A Valsecchi, Maria Grazia %A Decorti, Giuliana %A Rabusin, Marco %K Adolescent %K Antineoplastic Agents %K Child %K Child, Preschool %K Drug Resistance, Neoplasm %K Female %K Genotype %K Humans %K Infant %K Leukemia, Lymphocytic, Chronic, B-Cell %K Male %K Phenotype %K Precursor Cell Lymphoblastic Leukemia-Lymphoma %K Precursor T-Cell Lymphoblastic Leukemia-Lymphoma %K Recurrence %K Risk Assessment %K Steroids %K Tumor Necrosis Factor-alpha %X

AIM: In the AIEOP-BFM ALL (Associazione Italiana Ematologia Oncologia Pediatrica-Berlin Frankfurt Münster acute lymphoblastic leukemia) 2000 protocol, 70% of relapsed patients had favorable prognostic features and fell within less intensive polychemotherapeutic regimens, suggesting the need for better assessing lower risk stratification.

MATERIALS & METHODS: A novel two-phase study design selected 614 children to be genotyped for TNF-α SNP rs1800629 (-308G>A). A weighted Cox model was applied to evaluate the SNP effect on hazard of relapse, adjusting for immunophenotype, risk group, age and gender and including interaction terms.

RESULTS: Significant interaction was found with immunophenotypes (p = 0.0007, with minor allele genotypes being adverse genetic markers in B-cell acute lymphoblastic leukemia and protective ones in T-cell acute lymphoblastic leukemia), and also with risk protocols (p = 0.0041, with minor allele genotypes as prognostic factor of relapse for standard risk patients [only one T-cell acute lymphoblastic leukemia in the subgroup analyzed]).

CONCLUSION: The presence of at least one A allele in TNF-α SNP rs1800629 should suggest a closer monitoring in B-cell acute lymphoblastic leukemia standard risk patients.

%B Pharmacogenomics %V 15 %P 619-27 %8 2014 Apr %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/24798719?dopt=Abstract %R 10.2217/pgs.13.249 %0 Journal Article %J Med Hypotheses %D 2012 %T A common genetic background could explain early-onset Crohn's disease. %A Bianco, Anna Monica %A Zanin, Valentina %A Girardelli, Martina %A Magnolato, Andrea %A Martelossi, Stefano %A Martellossi, Stefano %A Tommasini, Alberto %A Marcuzzi, Annalisa %A Crovella, Sergio %K Crohn Disease %K Genetic Linkage %K Genetic Predisposition to Disease %K Humans %K Models, Biological %X

Crohn's disease (CD) is a multifactorial disease, in which environmental, microbial and genetic factors play important roles. CD is characterized by a chronic granulomatous inflammation by necrotic scarring with aspects of full-thickness wall. In spite of affecting mainly young adults, sometimes, CD can be present in the first year of life (early onset Crohn disease, EOCD) showing an unpredictable course and being often more severe than at older ages. In this paper we propose the hypothesis that EOCD patients should be analyzed using a Mendelian approach with family studies aimed to identify new loci directly involved in the early onset Crohn's disease. So we will leave the classic association study approach used until now for the identification of genes responsible for susceptibility to CD and propose linkage family analysis as alternative and powerful tool for the identification of new genetic variants associated with familiar cases of EOCD.

%B Med Hypotheses %V 78 %P 520-2 %8 2012 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22309886?dopt=Abstract %R 10.1016/j.mehy.2012.01.023 %0 Journal Article %J Curr Pharm Des %D 2012 %T Defective and excessive immunities in pediatric diseases. %A Notarangelo, Luigi Daniele %A Tommasini, Alberto %K Autoimmune Diseases %K Child %K Drug Design %K Humans %K Immunologic Deficiency Syndromes %K Inflammation %K Lymphocyte Activation %K Severity of Illness Index %X

Inflammatory and autoimmune diseases are classically considered as disorders arising from hyper-activation of immunity and hence are treated with drugs that suppress the lymphocyte activation and inflammation. Although this strategy has proven useful to cure symptoms, it rarely can heal the disease and long-term treatments are usually needed. Inflammatory and autoimmune diseases frequently occur also in patients with primary immune deficiency disease, proving that immune hyper-activation may paradoxically arise from defective function of immune genes. In these cases, the phenotype of hyper-activation is believed to reflect the attempts of the immune system to compensate for immune defects. Recent data suggest that similar mechanisms could be involved also in the pathogenesis of some multifactorial disorders, such as Crohn's disease and systemic lupus erythematosus. Based on these considerations, novel therapies could be developed to cure severe autoimmune and inflammatory disorders, not only by aiming to hyper-activation but as well by focusing on the possible underlying immune defects.

%B Curr Pharm Des %V 18 %P 5729-34 %8 2012 %G eng %N 35 %1 http://www.ncbi.nlm.nih.gov/pubmed/22726115?dopt=Abstract %0 Journal Article %J Pediatr Blood Cancer %D 2012 %T Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS). %A Tommasini, Alberto %A Valencic, Erica %A Piscianz, Elisa %A Rabusin, Marco %K Antineoplastic Agents %K Autoimmune Lymphoproliferative Syndrome %K Diseases in Twins %K Humans %K Male %K Pentostatin %B Pediatr Blood Cancer %V 58 %P 310; author reply 311 %8 2012 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21674759?dopt=Abstract %R 10.1002/pbc.23205 %0 Journal Article %J Gene %D 2012 %T Inflammation profile of four early onset Crohn patients. %A Marcuzzi, Annalisa %A Girardelli, Martina %A Bianco, Anna Monica %A Martelossi, Stefano %A Magnolato, Andrea %A Tommasini, Alberto %A Crovella, Sergio %K Crohn Disease %K Cytokines %K Humans %K Inflammation %K Monocytes %K Nod2 Signaling Adaptor Protein %K Polymorphism, Genetic %K Receptors, Interleukin-10 %K Tumor Necrosis Factor-alpha %X

Crohn disease (CD) is a multifactorial disorder affecting mainly young adults. Sometimes, however, it can present in the first year of life (Early onset Crohn disease (EOCD)) showing an unpredictable course and can often be more severe than at older ages. Some cases have been associated to an underlying primary immunodeficiency such as IL10R deficiency. We studied the functional response to IL-10 and the genotype of IL-10 receptor in four patients with early onset crohn-like colitis. We found an IL10R variant, which may be associated with a decreased response to the cytokine in one patient. Further studies to determine its pathogenic effect should be performed. In addition IL-10 mediated inhibition of LPS-induced TNFα expression was measured in patient's monocytes.

%B Gene %V 493 %P 282-5 %8 2012 Feb 10 %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22155628?dopt=Abstract %R 10.1016/j.gene.2011.11.043 %0 Journal Article %J Inflamm Bowel Dis %D 2012 %T JCV+ Patients with Inflammatory bowel disease show elevated plasma levels of MIG and SCF. %A Comar, Manola %A Secchiero, Paola %A De Lorenzo, Elisa %A Martelossi, Stefano %A Tommasini, Alberto %A Zauli, Giorgio %K Adolescent %K Adult %K Chemokine CXCL9 %K Child %K DNA, Viral %K Female %K Humans %K Inflammatory Bowel Diseases %K JC Virus %K Leukoencephalopathy, Progressive Multifocal %K Male %K Stem Cell Factor %K Young Adult %B Inflamm Bowel Dis %V 18 %P 1194-6 %8 2012 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22467521?dopt=Abstract %R 10.1002/ibd.22953 %0 Journal Article %J Hum Immunol %D 2012 %T The MDM2 inhibitor Nutlin-3 modulates dendritic cell-induced T cell proliferation. %A Gasparini, Chiara %A Tommasini, Alberto %A Zauli, Giorgio %K Dendritic Cells %K Humans %K Imidazoles %K Immunologic Factors %K Immunophenotyping %K Lymphocyte Activation %K Piperazines %K Proto-Oncogene Proteins c-mdm2 %K T-Lymphocytes %X

Nutlin-3, a small molecule inhibitor of the MDM2/p53 interaction, has been recently taken into consideration as a promising therapeutic tool for tumor treatment based on its ability to stabilize and activate the p53 transcription factor pathway. Since Nutlin-3 displays non cell-autonomous tumor-suppressor activities, we wanted to investigate its effect on dendritic cell functions, given the central role of these cells in the modulation of the immune response. We found that Nutlin-3 alone slightly affected the levels of major histocompatibility complex and costimulatory molecules and significantly promoted the ability of dendritic cells to stimulate T cells in the mixed lymphocyte reaction. Taken together, our findings suggest that the ability of Nutlin-3 to modulate dendritic cell functions and therefore lymphocyte proliferation might represent an additional important mechanism by which Nutlin-3 exerts its non cell-autonomous tumor-suppression function.

%B Hum Immunol %V 73 %P 342-5 %8 2012 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/22374325?dopt=Abstract %R 10.1016/j.humimm.2012.01.018 %0 Journal Article %J Acta Paediatr %D 2012 %T A red baby should not be taken too lightly. %A Faletra, Flavio %A Bruno, Irene %A Berti, Irene %A Pastore, Serena %A Pirrone, Angela %A Tommasini, Alberto %K Child, Preschool %K Dermatitis %K Ectodermal Dysplasia %K Female %K Humans %K Immunologic Deficiency Syndromes %K Infant %K Male %K Netherton Syndrome %K Severe Combined Immunodeficiency %K Skin %X

AIM: To identify clinical and laboratory features that can drive the differential diagnosis of a primary immunodeficiency diseases in patients with ectodermal defects.

METHODS: Analysis of selected teaching cases.

RESULTS: We identified four exemplary cases that allowed to point out specific clues.

CONCLUSIONS: A careful evaluation of immune and ectodermal signs is the key to the diagnosis. Therefore, a multidisciplinary approach can lead to diagnosis and to an appropriate treatment in most of the cases.

%B Acta Paediatr %V 101 %P e573-7 %8 2012 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/22946961?dopt=Abstract %R 10.1111/apa.12018 %0 Journal Article %J World J Gastroenterol %D 2011 %T Ages of celiac disease: from changing environment to improved diagnostics. %A Tommasini, Alberto %A Not, Tarcisio %A Ventura, Alessandro %K Autoantibodies %K Celiac Disease %K Diet, Gluten-Free %K Gliadin %K Glutens %K History, 19th Century %K History, 20th Century %K History, 21st Century %K History, Ancient %K History, Medieval %K Humans %K Transglutaminases %X

From the time of Gee's landmark writings, the recent history of celiac disease (CD) can be divided into many ages, each driven by a diagnostic advance and a deeper knowledge of disease pathogenesis. At the same time, these advances were paralleled by the identification of new clinical patterns associated with CD and by a continuous redefinition of the prevalence of the disease in population. In the beginning, CD was considered a chronic indigestion, even if the causative food was not known; later, the disease was proven to depend on an intolerance to wheat gliadin, leading to typical mucosal changes in the gut and to a malabsorption syndrome. This knowledge led to curing the disease with a gluten-free diet. After the identification of antibodies to gluten (AGA) in the serum of patients and the identification of gluten-specific lymphocytes in the mucosa, CD was described as an immune disorder, resembling a chronic "gluten infection". The use of serological testing for AGA allowed identification of the higher prevalence of this disorder, revealing atypical patterns of presentation. More recently, the characterization of autoantibodies to endomysium and to transglutaminase shifted the attention to a complex autoimmune pathogenesis and to the increased risk of developing autoimmune disorders in untreated CD. New diagnostic assays, based on molecular technologies, will introduce new changes, with the promise of better defining the spectrum of gluten reactivity and the real burden of gluten related-disorders in the population. Herein, we describe the different periods of CD experience, and further developments for the next celiac age will be proposed.

%B World J Gastroenterol %V 17 %P 3665-71 %8 2011 Aug 28 %G eng %N 32 %1 http://www.ncbi.nlm.nih.gov/pubmed/21990947?dopt=Abstract %R 10.3748/wjg.v17.i32.3665 %0 Journal Article %J Int Immunopharmacol %D 2011 %T Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. %A Piscianz, Elisa %A Cuzzoni, Eva %A De Iudicibus, Sara %A Valencic, Erica %A Decorti, Giuliana %A Tommasini, Alberto %K 3-Hydroxyanthranilic Acid %K Boronic Acids %K Cell Survival %K Cells, Cultured %K Humans %K Lymphocyte Activation %K Lymphocytes %K Manganese %K Pyrazines %X

Lymphocytes proliferation after antigen-driven activation leads to an increase in cell count, which could last some week, until apoptosis mechanisms allow the homeostatic control of the system. During the first days of this stimulation, activated lymphocytes display high resistance to apoptosis and to most immunosuppressive drugs. According to the literature, few compounds have been described to kill recently activated cells, by inhibiting metabolic processes fundamental to proliferation. The aim of our work was to evaluate comparatively these different compounds, in order to identify the best strategy to kill cells that have undergone proliferation, while sparing the repertoire of resting cells. After preliminary experiments, 3-HAA and bortezomib were selected as the most suitable compounds for our purposes. The possible synergic effect of 3-HAA with bortezomib or with manganese ions was also assessed. 3-HAA was confirmed to be the most reliable pharmacologic approach to inhibit proliferation with acceptable toxicity on resting cells. While in the case of PHA stimulation 3-HAA led to death of most lymphocytes, only a minor percentage of cells were killed after allo-stimulation, suggesting that the effect is proportional to the percentage of stimulated lymphocytes. Manganese ions further enhanced this effect, while results with bortezomib seemed to be less consistent. These results deserve further investigations to develop new procedures for targeting activated cells with pharmacological approaches.

%B Int Immunopharmacol %V 11 %P 2242-5 %8 2011 Dec %G eng %N 12 %1 http://www.ncbi.nlm.nih.gov/pubmed/21979495?dopt=Abstract %R 10.1016/j.intimp.2011.09.009 %0 Journal Article %J Pediatr Res %D 2011 %T The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. %A Marcuzzi, Annalisa %A De Leo, Luigina %A Decorti, Giuliana %A Crovella, Sergio %A Tommasini, Alberto %A Pontillo, Alessandra %K Alendronate %K Animals %K Anti-Inflammatory Agents %K Cell Line %K Child %K Child, Preschool %K Cholesterol %K Cytokines %K Dose-Response Relationship, Drug %K Enzyme Inhibitors %K Farnesyltranstransferase %K Humans %K Inflammation Mediators %K Lovastatin %K Male %K Mevalonate Kinase Deficiency %K Mice %K Monocytes %K Phosphotransferases (Alcohol Group Acceptor) %K Piperidines %K Polyenes %K Polyisoprenyl Phosphates %K Polyunsaturated Alkamides %K Pyridines %K Quinolones %K Terpenes %X

The shortage of geranylgeranyl-pyrophosphate (GGPP) was associated to an increased IL-1β release in the autoinflammatory syndrome mevalonate kinase deficiency (MKD), a rare inherited disease that has no specific therapy. Farnesyltransferase inhibitors (FTIs) act at the end of mevalonate pathway. Two FTIs, tipifarnib (Tip) and lonafarnib (Lon), were therefore evaluated as possible therapeutical choices for the treatment of MKD. FTIs could lead to a redirection of the limited available number of mevalonate intermediates preferentially to GGPP synthesis, eventually preventing the uncontrolled inflammatory response. The effect of Tip and Lon on intracellular cholesterol level (ICL) and on proinflammatory cytokines secretion was evaluated in a cellular model of MKD, chemically obtained treating RAW 264.7 cells with lovastatin (Lova) and alendronate (Ald). The combination of FTIs with the isoprenoid geraniol (GOH) was also tested both in this model and in monocytes isolated from MKD patients. Tip and Lon proved to revert the ICL lowering and to significantly reduce the lipopolysaccharide-induced cytokines secretion in Ald-Lova -RAW 264.7 cells. This anti-inflammatory effect was amplified combining the use of GOH with FTIs. The effect of GOH and Tip was successfully replicated in MKD patients' monocytes. Tip and Lon showed a dramatic anti-inflammatory effect in monocytes where mevalonate pathway was chemically or genetically impaired.

%B Pediatr Res %V 70 %P 78-82 %8 2011 Jul %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/21430599?dopt=Abstract %R 10.1038/pr.2011.303 %0 Journal Article %J J Allergy Clin Immunol %D 2011 %T Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. %A Passerini, Laura %A Olek, Sven %A Di Nunzio, Sara %A Barzaghi, Federica %A Hambleton, Sophie %A Abinun, Mario %A Tommasini, Alberto %A Vignola, Silvia %A Cipolli, Marco %A Amendola, Mario %A Naldini, Luigi %A Guidi, Luisa %A Cecconi, Massimiliano %A Roncarolo, Maria G %A Bacchetta, Rosa %K Forkhead Transcription Factors %K Gene Expression Regulation %K Genetic Diseases, X-Linked %K Humans %K Immunologic Deficiency Syndromes %K Intestinal Diseases %K Male %K Mutation %K Polyendocrinopathies, Autoimmune %B J Allergy Clin Immunol %V 128 %P 1376-1379.e1 %8 2011 Dec %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/22000569?dopt=Abstract %R 10.1016/j.jaci.2011.09.010 %0 Journal Article %J Eur J Immunol %D 2011 %T Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. %A Passerini, Laura %A Di Nunzio, Sara %A Gregori, Silvia %A Gambineri, Eleonora %A Cecconi, Massimiliano %A Seidel, Markus G %A Cazzola, Giantonio %A Perroni, Lucia %A Tommasini, Alberto %A Vignola, Silvia %A Guidi, Luisa %A Roncarolo, Maria G %A Bacchetta, Rosa %K Cell Differentiation %K Cell Lineage %K Cells, Cultured %K Enteritis %K Forkhead Transcription Factors %K Genetic Diseases, X-Linked %K Humans %K Immunity, Innate %K Interleukin-2 Receptor alpha Subunit %K Mutation %K Polyendocrinopathies, Autoimmune %K Syndrome %K T-Lymphocytes, Regulatory %X

Mutations of forkhead box p3 (FOXP3), the master gene for naturally occurring regulatory T cells (nTregs), are responsible for the impaired function of nTregs, resulting in an autoimmune disease known as the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. The relevance of other peripheral tolerance mechanisms, such as the presence and function of type 1 regulatory T (Tr1) cells, the major adaptive IL-10-producing Treg subset, in patients with IPEX syndrome remains to be clarified. FOXP3(mutated) Tr1-polarized cells, differentiated in vitro from CD4(+) T cells of four IPEX patients, were enriched in IL-10(+) IL-4(-) IFN-γ(+) T cells, a cytokine production profile specific for Tr1 cells, and expressed low levels of FOXP3 and high levels of Granzyme-B. IPEX Tr1 cells were hypoproliferative and suppressive, thus indicating that FOXP3 mutations did not impair their function. Furthermore, we isolated Tr1 cell clones from the peripheral blood of one FOXP3(null) patient, demonstrating that Tr1 cells are present in vivo and they can be expanded in vitro in the absence of WT FOXP3. Overall, our results (i) show that functional Tr1 cells differentiate independently of FOXP3, (ii) confirm that human Tr1 and nTregs are distinct T-cell lineages, and (iii) suggest that under favorable conditions Tr1 cells could exert regulatory functions in IPEX patients.

%B Eur J Immunol %V 41 %P 1120-31 %8 2011 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/21400500?dopt=Abstract %R 10.1002/eji.201040909 %0 Journal Article %J Pathology %D 2011 %T Gastrointestinal Foxp3 expression in normal, inflammatory and neoplastic conditions. %A Villanacci, Vincenzo %A Not, Tarcisio %A Nascimbeni, Riccardo %A Ferrara, Fortunato %A Tommasini, Alberto %A Manenti, Stefania %A Antonelli, Elisabetta %A Bassotti, Gabrio %K Adult %K Aged %K Celiac Disease %K Cell Count %K Disease Progression %K Esophagitis %K Female %K Forkhead Transcription Factors %K Gastric Mucosa %K Gastritis %K Humans %K Inflammatory Bowel Diseases %K Lymphocytes %K Male %K Middle Aged %K Precancerous Conditions %K Stomach Diseases %K Stomach Neoplasms %K Young Adult %X

BACKGROUND: Foxp3(+) regulatory T lymphocytes (T-regs) represent an important regulatory cell subset in inflammatory, preneoplastic and neoplastic conditions of the gastrointestinal tract.

METHODS: Inflammatory, preneoplastic and neoplastic conditions of the gastrointestinal tract (189 cases) were studied with the evaluation of Foxp3 regulatory T cells based on immunohistochemistry.

RESULTS: Few Foxp3(+) cells were found in controls and inflammatory conditions (oesophagitis, gastritis, coeliac disease, inflammatory bowel disease); in preneoplastic and neoplastic conditions the number of Foxp3(+) cells was significatively increased.

CONCLUSIONS: In normal conditions the number of mucosal lymphocytes is very low throughout the gastro-intestinal tract; in active coeliac disease patients or on a gluten-free diet, only a slight increase in Foxp3(+) cells may be found. Gastrointestinal cancers are associated with higher Foxp3(+) cell proportion, compared with microscopically normal tissue and with precancerous conditions. However, it is uncertain whether the increase in these regulatory cells is a cause or a consequence of tumour progression.

%B Pathology %V 43 %P 465-71 %8 2011 Aug %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/21670722?dopt=Abstract %R 10.1097/PAT.0b013e3283485e37 %0 Journal Article %J Inflamm Res %D 2010 %T Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. %A Marcuzzi, Annalisa %A Decorti, Giuliana %A Pontillo, Alessandra %A Ventura, Alessandro %A Tommasini, Alberto %K Animals %K Anti-Inflammatory Agents %K Cholesterol %K Disease Models, Animal %K Inflammation %K Interleukin-1beta %K Male %K Mevalonate Kinase Deficiency %K Mice %K Mice, Inbred BALB C %K Random Allocation %K Terpenes %X

OBJECTIVE: The aim of this study was to evaluate, in a mouse model of mevalonate kinase deficiency (MKD), the possible link between inflammatory symptoms and serum cholesterol levels.

MATERIALS AND METHODS: Balb/c mice were treated with alendronate and bacterial muramyl dipeptide. Body temperature, interleukin-1 beta (IL-1 beta) secretion and serum cholesterol levels were measured.

RESULTS: An increased production of the pro-inflammatory cytokine IL-1 beta (p < 0.05) and a rise in body temperature (p < 0.05) was observed, while, in parallel, serum cholesterol concentration significantly decreased (p < 0.05). These effects were completely reversed when animals were treated with exogenous isoprenoids.

CONCLUSIONS: In the mouse model of MKD, the inflammatory response is associated with a reduction in cholesterol levels, and hence this parameter could be used as an indicator of isoprenoid consumption. In addition, plant derived isoprenoids could represent candidate treatments for this disease.

%B Inflamm Res %V 59 %P 335-8 %8 2010 May %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/20174853?dopt=Abstract %R 10.1007/s00011-010-0168-6 %0 Journal Article %J J Pediatr %D 2010 %T Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra. %A Lepore, Loredana %A Paloni, Giulia %A Caorsi, Roberta %A Alessio, Maria %A Rigante, Donato %A Ruperto, Nicola %A Cattalini, Marco %A Tommasini, Alberto %A Zulian, Francesco %A Ventura, Alessando %A Martini, Alberto %A Gattorno, Marco %K Adolescent %K Adult %K Case-Control Studies %K Child %K Child, Preschool %K Cryopyrin-Associated Periodic Syndromes %K Female %K Follow-Up Studies %K Humans %K Inflammation %K Interleukin 1 Receptor Antagonist Protein %K Interleukin-1 %K Male %K Phenotype %K Quality of Health Care %K Quality of Life %K Questionnaires %K Syndrome %K Treatment Outcome %X

OBJECTIVE: To evaluate the quality of life and long-term follow-up of patients enrolled in the Italian registry of cryopyrin-associated periodic syndromes (CAPS).

STUDY DESIGN: Since 2004, 20 patients with CAPS were enrolled in a common registry from different Italian Centers of Pediatric Rheumatology; 14 patients were treated with Anakinra in an open fashion. Both treated and untreated patients were routinely followed according to standard of care. The Child Health Questionnaire (CHQ-PF 50) was used to assess the health-related quality of life.

RESULTS: The mean duration of follow-up was 37.5 months. In all treated patients, a complete and persistent control of the inflammatory manifestations was observed with no further progression of the disease. At enrollment in the registry, patients showed a poorer health-related quality of life than healthy children in both physical and the psychosocial summary scores. Treatment was associated with a dramatic and sustained amelioration of a variety of measures of poor quality of life, particularly in those concerning the global health perception, bodily pain-discomfort, and other physical domains.

CONCLUSIONS: Long-term IL-1 blockade produces a significant and persistent improvement in the clinical manifestations associated with the disease and on the overall quality of life.

%B J Pediatr %V 157 %P 310-315.e1 %8 2010 Aug %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/20472245?dopt=Abstract %R 10.1016/j.jpeds.2010.02.040 %0 Journal Article %J Int Immunopharmacol %D 2010 %T Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. %A Marcuzzi, Annalisa %A Tommasini, Alberto %A Crovella, Sergio %A Pontillo, Alessandra %K Animals %K Cell Line %K Cells, Cultured %K Child %K Child, Preschool %K Cytokines %K Diphosphonates %K Humans %K Inflammation %K Interleukin-1beta %K Lipopolysaccharides %K Male %K Mevalonate Kinase Deficiency %K Mice %K Monocytes %K Nitric Oxide %K Terpenes %X

The inhibition of mevalonate pathway through genetic defects (mevalonate kinase deficiency, MKD) or pharmacologic drugs (aminobisphosphonates) causes a shortage of intermediate compounds and, in particular, of geranylgeranyl-pyrophosphate (GGPP) associated to the activation of caspase-1 and IL-1beta release. Geraniol (GOH), farnesol (FOH), geranylgeraniol (GGOH) and menthol (MOH), due to their isoprenoid structure, are supposed to enter the mevalonate pathway and to by-pass the biochemical block, reconstituting the pathway. Considering the already known side effects of aminobisphosphonates, and the lack of a specific treatment for MKD, we evaluated the impact of these natural isoprenoids compounds in a RAW cell lines chemically treated with the aminobisphosphonate alendronate, and in monocytes isolated from 2 patients affected by MKD. GOH, FOH, GGOH and MOH were all capable to diminish inflammatory marker levels induced by LPS. These natural isoprenoids could be proposed as novel therapeutic approach for the still orphan drug MKD, but also considered for the evaluation of possible inflammatory side effects of aminobisphosphonates.

%B Int Immunopharmacol %V 10 %P 639-42 %8 2010 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20304105?dopt=Abstract %R 10.1016/j.intimp.2010.03.008 %0 Journal Article %J Pharmacol Res %D 2010 %T Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. %A De Leo, Luigina %A Marcuzzi, Annalisa %A Decorti, Giuliana %A Tommasini, Alberto %A Crovella, Sergio %A Pontillo, Alessandra %K Adult %K Animals %K Anti-Inflammatory Agents %K Cells, Cultured %K Child, Preschool %K Enzyme Inhibitors %K Farnesyltranstransferase %K Female %K Humans %K Male %K Mevalonate Kinase Deficiency %K Mevalonic Acid %K Mice %K Mice, Inbred BALB C %K Monocytes %K Polyenes %K Polyisoprenyl Phosphates %K Polyunsaturated Alkamides %K Young Adult %X

Mevalonate kinase deficiency (MKD) is a rare inborn auto-inflammatory disease due to the impairment of the pathway for the biosynthesis of cholesterol and non-sterol isoprenoids. The shortage of isoprenoids compounds and in particular of geranylgeranylpyrophosphate (GGPP) was recently associated to the MKD characteristic inflammatory attacks. The aim of this study is to demonstrate that the normalization of the mevalonate pathway intermediates levels and in particular of GGPP, through the specific inhibition of farnesyl-transferase (FT) with Manumycin A could ameliorate the inflammatory phenotype of MKD patients. The effect of Manumycin A was first evaluated in MKD mouse and cellular models, chemically obtained using the aminobisphosphonate alendronate (ALD), and then in monocytes isolated from 2 MKD patients. Our findings were compared to those obtained by using natural exogenous isoprenoids (NEIs). Manumycin A was able to significantly reduce the inflammatory marker serum amyloid A in ALD-treated Balb/c mice, as well as IL-1 beta secretion in ALD-monocytes and in MKD patients. These results clearly showed that, through the inhibition of FT, an increased number of mevalonate pathway intermediates could be redirected towards the synthesis of GGPP diminishing the inflammatory response. The importance in limiting the shortage of GGPP was emphasized by the anti-inflammatory effect of NEIs that, due to their biochemical structure, can enter the MKD pathway. In conclusion, manumycin A, as well as NEIs, showed anti-inflammatory effect in MKD models and especially in MKD-monocytes, suggesting novel approaches in the treatment of MKD, an orphan disease without any efficacious treatment currently available.

%B Pharmacol Res %V 61 %P 506-10 %8 2010 Jun %G eng %N 6 %1 http://www.ncbi.nlm.nih.gov/pubmed/20206266?dopt=Abstract %R 10.1016/j.phrs.2010.02.012 %0 Journal Article %J J Allergy Clin Immunol %D 2010 %T Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. %A Freudenberg, Folke %A Wintergerst, Uwe %A Roesen-Wolff, Angela %A Albert, Michael H %A Prell, Christine %A Strahm, Brigitte %A Koletzko, Sibylle %A Ehl, Stephan %A Roos, Dirk %A Tommasini, Alberto %A Ventura, Alessandro %A Belohradsky, Bernd H %A Seger, Reinhard %A Roesler, Joachim %A Güngör, Tayfun %K Age of Onset %K Anti-Bacterial Agents %K Antibodies, Monoclonal %K Child %K Drug Therapy, Combination %K Gene Deletion %K Granulomatous Disease, Chronic %K Humans %K Inflammatory Bowel Diseases %K Male %K NADPH Oxidase %K Steroids %K Treatment Outcome %K Vidarabine %B J Allergy Clin Immunol %V 125 %P 943-946.e1 %8 2010 Apr %G eng %N 4 %1 http://www.ncbi.nlm.nih.gov/pubmed/20371400?dopt=Abstract %R 10.1016/j.jaci.2010.01.035 %0 Journal Article %J Scand J Gastroenterol %D 2010 %T The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease? %A Tommasini, Alberto %A Pirrone, Angela %A Palla, Gabriella %A Taddio, Andrea %A Martelossi, Stefano %A Crovella, Sergio %A Ventura, Alessandro %K Biological Markers %K Crohn Disease %K Cytokines %K Evidence-Based Medicine %K Granulomatous Disease, Chronic %K Hematopoietic Stem Cell Transplantation %K Humans %K Immunosuppressive Agents %K Phagocytes %K Treatment Outcome %K Wiskott-Aldrich Syndrome %X

Crohn's disease (CD) is generally considered a multifactorial disorder, since different genetic and environmental factors are thought to play a role in its pathogenesis. Recently, genome wide linkage studies allowed to identify the association of several loci with the increased risk of CD, although it is still unclear how they interact with environmental factors in causing the disease. The fact that many CD-risk-related genes are involved in the function of phagocytes seems in agreement with the well known role of these cells in CD histopathology. Functional defects in cytokine production or in clearance of bacteria in CD patients have recently been reported. Growing evidence that CD could arise from primary phagocyte immunodeficiency is also coming from the study of cases with early onset in infancy. We review such evidences starting from selected cases and discuss the clinical implications of these findings.

%B Scand J Gastroenterol %V 45 %P 1141-9 %8 2010 Oct %G eng %N 10 %1 http://www.ncbi.nlm.nih.gov/pubmed/20497046?dopt=Abstract %R 10.3109/00365521.2010.492529